USA: Findings from a case-control study published in JAMA Network Open revealed a reduced risk of venous thromboembolism (VTE) with statin use in women exposed to hormone therapy (HT). Also, HT may not be contraindicated in women taking statins. The researchers revealed that in 223 949 women (50 to 64 years), VTE risk was 53% […]
China: A large cross-sectional study in Chongqing, China, has shed light on the association between alcohol consumption and the risk of hyperuricaemia among adults. The study findings published in BMJ Open have demonstrated the frequency and degree of alcohol consumption to be the risk factors for hyperuricemia (HUA), especially in males. Moderate drinking was also […]
Chronic kidney disease (CKD) is a prevalent global health issue, affecting 10% of the adult population worldwide, with a 29.3% increase in prevalence from 1990 to 2017. This condition is associated with an increased risk of mortality and cardiovascular disease (CVD). Early identification and prevention of CKD are crucial. Hong Zhang et al., in a […]
USA: Cord blood (CB) leptin may be a biomarker of future adiposity risk, a recent study has concluded. The research was a follow-up to the Hyperglycemia and Adverse Pregnancy Outcomes Follow-Up Study. The study, published in Pediatric Obesity revealed that CB leptin is positively associated with childhood and neonatal adiposity and child leptin levels, independent […]
A recent study by Michael Monica and team explored the cognitive effects of guayusa extract and Nordic Lion’s Mane (LM) that highlight their potential to enhance mental performance. Researchers have found in a new study that Guayusa Extract and Lion’s Mane Mushrooms enhance mood and cognitive function. The findings were published in Nutrients Journal. This […]
USA: Roflumilast topical foam, 0.3% has received approval from the US Food and Drug Administration (FDA), for the treatment of seborrheic dermatitis in those aged 9 years and older. The approval has been granted to Arcutis Biotherapeutics, Inc. Seborrheic dermatitis affects more than 10 million individuals in the US. ZORYVE foam provides rapid disease clearance […]
In a groundbreaking study, scientists have delved into the intricate relationship between infectious agents and the outcomes of high-grade serous epithelial ovarian cancer, a crucial but poorly understood aspect of the disease. The study revealed a significant association between the presence of viruses of interest (VOI) and lower overall survival, shedding light on potential implications […]
New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the phase 1b/III clinical study of the anti-cancer drug Capivasertib film-coated tablet 160mg or 200mg. However, this approval is subject to a condition that the Phase-Ib part of the […]
New Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin Hydrochloride (SR) uncoated bilayered tablet, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akum Pharmaceutical that the Phase III clinical trial protocol should be adequately […]
Surat: The District Consumer Disputes Redressal Commission (DCDRC), Bharuch recently turned down the plea for compensation by a doctor, who alleged that his kidney was wrongfully removed based on a Vadodara-based pathology laboratory’s report. It was mentioned in the said report that the tumour in the kidney “could be cancerous”. Later a CT scan was done […]